Literature DB >> 22938409

siRNA-mediated silencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells.

Qi-Fa Ye1, Yi-Chuan Zhang, Xiao-Qing Peng, Zhi Long, Ying-Zi Ming, Le-Ye He.   

Abstract

PURPOSE: Notch is an important signaling pathway that regulates cell fate, stem cell maintenance and the initiation of differentiation in many tissues. It has been reported that activation of Notch-1 contributes to tumorigenesis. However, whether Notch signaling might have a role in chemoresistance of prostate cancer is unclear. This study aimed to investigate the effects of Notch-1 silencing on the sensitivity of prostate cancer cells to docetaxel treatment.
METHODS: siRNA against Notch-1 was transfected into PC-3 prostate cancer cells. Proliferation, apoptosis and cell cycle distribution were examined in the presence or absence of docetaxel by MTT and flow cytometry. Expression of p21(waf1/cip1) and Akt as well as activation of Akt in PC-3 cells were detected by Western blot and Real-time PCR.
RESULTS: Silencing of Notch-1 promoted docetaxel induced cell growth inhibition, apoptosis and cell cycle arrest in PC-3 cells. In addition, these effects were associated with increased p21(waf1/cip1) expression and decreased Akt expression and activation in PC-3 cells.
CONCLUSION: Notch-1 promotes chemoresistance of prostate cancer and could be a potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938409     DOI: 10.7314/apjcp.2012.13.6.2485

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  14 in total

Review 1.  Hypoxia, notch signalling, and prostate cancer.

Authors:  Laure Marignol; Karla Rivera-Figueroa; Thomas Lynch; Donal Hollywood
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

2.  Identification, characterization and targeting of Docetaxel-resistant prostate cancer cells.

Authors:  Tanya I Stoyanova; Andrew S Goldstein
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

3.  Activation of Notch pathway is linked with epithelial-mesenchymal transition in prostate cancer cells.

Authors:  Lianhua Zhang; Jianjun Sha; Guoliang Yang; Xuyuan Huang; Juanjie Bo; Yiran Huang
Journal:  Cell Cycle       Date:  2017-04-07       Impact factor: 4.534

Review 4.  The Notch signaling pathway as a mediator of tumor survival.

Authors:  Kathleen M Capaccione; Sharon R Pine
Journal:  Carcinogenesis       Date:  2013-04-12       Impact factor: 4.944

5.  Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma.

Authors:  Wen-Rui Wu; Xiang-De Shi; Rui Zhang; Man-Sheng Zhu; Lei-Bo Xu; Xian-Huan Yu; Hong Zeng; Jie Wang; Chao Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

6.  Notch-1 knockdown suppresses proliferation, migration and metastasis of salivary adenoid cystic carcinoma cells.

Authors:  Wei Chen; Gang Cao; Xinran Yuan; Xiang Zhang; Qingqing Zhang; Yinglan Zhu; Zhen Dong; Senlin Zhang
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

7.  Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.

Authors:  Vincenza Cifarelli; Laura M Lashinger; Kaylyn L Devlin; Sarah M Dunlap; Jennifer Huang; Rudolf Kaaks; Michael N Pollak; Stephen D Hursting
Journal:  Diabetes       Date:  2015-01-09       Impact factor: 9.461

Review 8.  Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Catia Giovannini; Luigi Bolondi; Laura Gramantieri
Journal:  Int J Mol Sci       Date:  2016-12-28       Impact factor: 5.923

Review 9.  A Review on Notch Signaling and Colorectal Cancer.

Authors:  Ashish Tyagi; Arun K Sharma; Chendil Damodaran
Journal:  Cells       Date:  2020-06-25       Impact factor: 6.600

10.  Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.

Authors:  Bin Song; Heyang Cui; Yaoping Li; Caixia Cheng; Bin Yang; Fang Wang; Pengzhou Kong; Hongyi Li; Ling Zhang; Zhiwu Jia; Yanghui Bi; Jiaqian Wang; Yong Zhou; Jing Liu; Juan Wang; Zhenxiang Zhao; Yanyan Zhang; Xiaoling Hu; Ruyi Shi; Jie Yang; Haiyan Liu; Ting Yan; Yike Li; Enwei Xu; Yu Qian; Yanfeng Xi; Shiping Guo; Yunqing Chen; Jinfen Wang; Guodong Li; Jianfang Liang; Junmei Jia; Xing Chen; Jiansheng Guo; Tong Wang; Yanbo Zhang; Qingshan Li; Chuangui Wang; Xiaolong Cheng; Qimin Zhan; Yongping Cui
Journal:  Oncotarget       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.